Background
Medication harm has negative clinical and economic consequences,
contributing to hospitalisation, morbidity and mortality. The incidence
ranges from four to 14%, of which up to 50% of events may be
preventable. A predictive model for identifying high-risk inpatients can
guide a timely and systematic approach to prioritisation.